XORTX Therapeutics, Inc. XRTX 深 滬
已收盤 05-08 16:00:00 美东时间
2.79
+0.140
+5.28%
華盛通- 最 高2.79
- 今 開2.60
- 成交量 1.74万股
- 最 低 2.60
- 昨 收 2.65
- 總市值 431.61万
- 52周最高 7.05
- 市盈率 靜 --
- 換手率 1.12%
- 52周最低 1.725
- 委 比 12.59%
- 總股本 154.70万
- 歷史最高 265.05
- 量 比 0.85
- 振 幅 7.17%
- 歷史最低 1.725
- 每 手 1
- 風險率 0.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
XORTX Therapeutics Receives Letter Of Compliance From Nasdaq
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
04-21 19:21
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers XORTX Therapeutics (NASDAQ:XRTX) shares increased by 53.8% to $3.4 dur...
04-14 05:05
XORTX Therapeutics Delays 1-for-5 Share Consolidation To April 6, Pending Approvals
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive
03-27 04:42
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05
Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Align Technology Inc (NASDAQ:ALGN) rose sharply in pre-market trading...
02-05 17:34
Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket
Shares of Lucas GC Limited (NASDAQ:LGCL) rose sharply in pre-market trading aft...
2025-11-03 18:09
XORTX Therapeutics Announces US$1.1 Million Direct Offering
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has provided an update. On October 21, 2...
2025-10-21 20:27
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Replimune Group (NASDAQ:REPL) shares rose 119.1% to $9.86 during Monda...
2025-10-21 02:39
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
XORTX Therapeutics received a notice from Nasdaq granting a 180-day extension to meet the minimum bid price requirement of US$1.00 per share by April 13, 2026. If compliance is not achieved, the company may face delisting and could appeal the decision. XORTX continues to develop therapies for gout, progressive kidney disease, and acute kidney injury.
2025-10-21 00:34
